CDSCO Launched National Single Window System (NSWS) Portal

On January 01, 2024, the notice was issued by the Central Drugs Standard Control Organization (CDSCO) of India to all stakeholders, announcing the establishment of the National Single Window System (NSWS). This system aims to streamline investor approvals and simplify business transactions by serving as a unified platform for obtaining approvals, licenses, registrations, and clearances as required.

The NSWS represents a paradigm shift in how regulatory approvals are processed in India, bringing together multiple regulatory bodies under one digital umbrella.

Features of NSWS:

• Single point of entry for all regulatory approvals
• Integration with multiple government departments
• Automated workflow management
• Digital document management
• Real-time status updates

This initiative is expected to significantly reduce the time and effort required for obtaining regulatory approvals, making India a more attractive destination for pharmaceutical and medical device investments.